13/12/2024, 5:34:02 pm

Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal

Blackstone and Bain Capital are among the final bidders for Mitsubishi Tanabe Pharma, a unit of Mitsubishi Chemical Group, in a deal valued between $3 billion and $3.5 billion. The sale process, run by Goldman Sachs, is expected to conclude by December 24. Local private equity firm Japan Industrial Partners is also bidding for the company.